Zoekresultaten - "Chimeric antigen receptor T cell"

Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma door Jain MD, Bachmeier CA, Phuoc VH, Chavez JC

Connect to this object online.

Current status of immunotherapy for non-small cell lung cancer door Tao Yang, Yilin Xiong, Yufei Zeng, Yan Wang, Jing Zeng, Jie Liu, Shangfu Xu, Li-Sheng Li

Connect to this object online.

Single-cell analysis of the survival mechanisms of fratricidal CAR-T targeting of T cell malignancies door Hui Hu, Ling Tang, Yuyan Zhao, Jiali Cheng, Mei Huang, Yong You, Ping Zou, Qian Lei, Xiaojian Zhu, An-Yuan Guo

Connect to this object online.

Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy door Jianshu Zhu, Jiawei Fan, Yuanliang Xia, Hengyi Wang, Yuehong Li, Zijia Feng, Changfeng Fu

Connect to this object online.

Romidepsin Enhances the Killing Ability of NKG2D-CAR-T Cells through Enhanced Expression of NKG2DL against Ovarian Cancer Cells door Liang Wang, Xite Lin, Lirui Yu, Pengming Sun

Connect to this object online.

CAR-T therapy pulmonary adverse event profile: a pharmacovigilance study based on FAERS database (2017-2023) door Jing Shi, Jing Shi, Xinya Liu, Xinya Liu, Yun Jiang, Mengjiao Gao, Jian Yu, Yuanming Zhang, Li Wu

Connect to this object online.

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia door Yadan Liu, Yadan Liu, Yadan Liu, Bin Liang, Bin Liang, Bin Liang, Bin Liang, Yan Liu, Guoqing Wei, Guoqing Wei, Guoqing Wei, Wenjun Wu, Wenjun Wu, Wenjun Wu, Luxin Yang, Luxin Yang, Luxin Yang, Li Yang, Li Yang, Li Yang, He Huang, He Huang, He Huang, Jue Xie, Yongxian Hu, Yongxian Hu, Yongxian Hu

Connect to this object online.

BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1 door Songnan Sui, Mengjun Zhong, Shuxin Zhong, Xueting Peng, Lipeng Mao, Cunte Chen, Chengwu Zeng, Oscar Junhong Luo, Yangqiu Li

Connect to this object online.

The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma door Vivian Jiang, William Lee, Tianci Zhang, Alexa Jordan, Fangfang Yan, Qingsong Cai, Joseph McIntosh, Jovanny Vargas, Yang Liu, Michael Wang

Connect to this object online.

Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Rel... door Pietro Merli, Marianne Ifversen, Tony H. Truong, Hanne V. Marquart, Jochen Buechner, Matthias Wölfl, Peter Bader

Connect to this object online.

Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain door Ribera Santasusana JM, de Andrés Saldaña A, García-Muñoz N, Gostkorzewicz J, Martínez Llinàs D, Díaz de Heredia C

Connect to this object online.

Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Sin... door Wang XJ, Wang YH, Ong MJC, Gkitzia C, Soh SY, Hwang WYK

Connect to this object online.

The basics of CAR T design and challenges in immunotherapy of solid tumors - Ovarian cancer as a model door Xuequn Xu, Jin Qiu, Yi Sun

Connect to this object online.

Cancer Immunotherapy and Biological Cancer Treatments

DOAB: download the publication
DOAB: description of the publication

Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma door Amandeep Aujla, Ravijot Aujla, Delong Liu

Connect to this object online.

Hospital pharmacist's roles and responsibilities with CAR-T medicines door María Estela Moreno-Martínez, Joan Vinent-Genestar, Carmen Muñoz-Sánchez, María Josep Carreras-Soler

Connect to this object online.

The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors door Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, Abdolreza Esmaeilzadeh

Connect to this object online.

CAR-based cell therapy: evaluation with bibliometrics and patent analysis door Yajun Yuan, Qihan Fu, Yaqun Zhang, Danhai Xu, Yeqing Wu, Qiufei Qiu, Wuyuan Zhou

Connect to this object online.

Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment door Guidong Zhu, Guidong Zhu, Guidong Zhu, Guidong Zhu, Qing Zhang, Qing Zhang, Qing Zhang, Junwen Zhang, Junwen Zhang, Junwen Zhang, Fusheng Liu, Fusheng Liu, Fusheng Liu

Connect to this object online.

The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs door Kaveh Hadiloo, Siavash Taremi, Salar Hozhabri Safa, Sima Amidifar, Abdolreza Esmaeilzadeh

Connect to this object online.